The global wearable cardioverter defibrillators market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of cardiovascular diseases and increasing awareness about the benefits of wearable cardioverter defibrillators.
The global wearable cardioverter defibrillators market by type is segmented into for peripartum cardiomyopathy, for inherited arrhythmias, and for congenital heart disease. The application segment includes hospitals, homecare settings, and specialty clinics. The regional segmentation includes North America, Latin America, Europe, Asia Pacific and Middle East & Africa.
-The global wearable cardioverter defibrillator market is expected to grow at a CAGR of around 8.5% during the forecast period, owing to the increasing prevalence of cardiovascular diseases and rising demand for wearable cardioverter defibrillators.
-The increasing number of people suffering from heart diseases is one of the major factors driving the growth in this market. The incidence rate for cardiovascular disease has been on an upward trend over the past few years, which has led to an increase in demand for wearable cardioverter defibrillators.
-Increasing awareness about cardiac arrest and its symptoms among people is also driving this market’s growth. Cardiac arrest can be fatal if not treated immediately, which makes it important for people to know about it and take preventive measures against it. Wearable cardioverter defibrillators are a good way to prevent cardiac arrest as they can detect arrhythmias and deliver shocks when needed.
Industry Growth Insights published a new data on “Wearable Cardioverter Defibrillators Market”. The research report is titled “Wearable Cardioverter Defibrillators Market research by Types (For Peripartum Cardiomyopathy, For Inherited Arrythmias, For Congenital Heart Disease), By Applications (Hospitals, Homecare Settings, Specialty Clinics), By Players/Companies Boston Scientific, St. Jude Medical, Medtronic, Nihon Kohden, Zoll Medical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Wearable Cardioverter Defibrillators Market Research Report
By Type
For Peripartum Cardiomyopathy, For Inherited Arrythmias, For Congenital Heart Disease
By Application
Hospitals, Homecare Settings, Specialty Clinics
By Companies
Boston Scientific, St. Jude Medical, Medtronic, Nihon Kohden, Zoll Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Wearable Cardioverter Defibrillators Market Report Segments:
The global Wearable Cardioverter Defibrillators market is segmented on the basis of:
Types
For Peripartum Cardiomyopathy, For Inherited Arrythmias, For Congenital Heart Disease
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Homecare Settings, Specialty Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific
- St. Jude Medical
- Medtronic
- Nihon Kohden
- Zoll Medical
Highlights of The Wearable Cardioverter Defibrillators Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- For Peripartum Cardiomyopathy
- For Inherited Arrythmias
- For Congenital Heart Disease
- By Application:
- Hospitals
- Homecare Settings
- Specialty Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Wearable Cardioverter Defibrillators Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Wearable cardioverter defibrillators (WCVDs) are devices that monitor heart rhythm and deliver an electric shock to correct it if necessary. They are worn on the chest like a watch and can be used to treat many different types of cardiac arrhythmias, including ventricular fibrillation (VF).
Some of the key players operating in the wearable cardioverter defibrillators market are Boston Scientific, St. Jude Medical, Medtronic, Nihon Kohden, Zoll Medical.
The wearable cardioverter defibrillators market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Wearable Cardioverter Defibrillators Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Wearable Cardioverter Defibrillators Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Wearable Cardioverter Defibrillators Market - Supply Chain
4.5. Global Wearable Cardioverter Defibrillators Market Forecast
4.5.1. Wearable Cardioverter Defibrillators Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Wearable Cardioverter Defibrillators Market Size (000 Units) and Y-o-Y Growth
4.5.3. Wearable Cardioverter Defibrillators Market Absolute $ Opportunity
5. Global Wearable Cardioverter Defibrillators Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Wearable Cardioverter Defibrillators Market Size and Volume Forecast by Type
5.3.1. For Peripartum Cardiomyopathy
5.3.2. For Inherited Arrythmias
5.3.3. For Congenital Heart Disease
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Wearable Cardioverter Defibrillators Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Wearable Cardioverter Defibrillators Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Homecare Settings
6.3.3. Specialty Clinics
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Wearable Cardioverter Defibrillators Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Wearable Cardioverter Defibrillators Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Wearable Cardioverter Defibrillators Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Wearable Cardioverter Defibrillators Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Wearable Cardioverter Defibrillators Demand Share Forecast, 2019-2026
9. North America Wearable Cardioverter Defibrillators Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Wearable Cardioverter Defibrillators Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Wearable Cardioverter Defibrillators Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Homecare Settings
9.4.3. Specialty Clinics
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Wearable Cardioverter Defibrillators Market Size and Volume Forecast by Type
9.7.1. For Peripartum Cardiomyopathy
9.7.2. For Inherited Arrythmias
9.7.3. For Congenital Heart Disease
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Wearable Cardioverter Defibrillators Demand Share Forecast, 2019-2026
10. Latin America Wearable Cardioverter Defibrillators Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Wearable Cardioverter Defibrillators Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Wearable Cardioverter Defibrillators Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Homecare Settings
10.4.3. Specialty Clinics
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Wearable Cardioverter Defibrillators Market Size and Volume Forecast by Type
10.7.1. For Peripartum Cardiomyopathy
10.7.2. For Inherited Arrythmias
10.7.3. For Congenital Heart Disease
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Wearable Cardioverter Defibrillators Demand Share Forecast, 2019-2026
11. Europe Wearable Cardioverter Defibrillators Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Wearable Cardioverter Defibrillators Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Wearable Cardioverter Defibrillators Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Homecare Settings
11.4.3. Specialty Clinics
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Wearable Cardioverter Defibrillators Market Size and Volume Forecast by Type
11.7.1. For Peripartum Cardiomyopathy
11.7.2. For Inherited Arrythmias
11.7.3. For Congenital Heart Disease
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Wearable Cardioverter Defibrillators Demand Share, 2019-2026
12. Asia Pacific Wearable Cardioverter Defibrillators Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Wearable Cardioverter Defibrillators Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Wearable Cardioverter Defibrillators Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Homecare Settings
12.4.3. Specialty Clinics
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Wearable Cardioverter Defibrillators Market Size and Volume Forecast by Type
12.7.1. For Peripartum Cardiomyopathy
12.7.2. For Inherited Arrythmias
12.7.3. For Congenital Heart Disease
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Wearable Cardioverter Defibrillators Demand Share, 2019-2026
13. Middle East & Africa Wearable Cardioverter Defibrillators Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Wearable Cardioverter Defibrillators Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Wearable Cardioverter Defibrillators Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Homecare Settings
13.4.3. Specialty Clinics
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Wearable Cardioverter Defibrillators Market Size and Volume Forecast by Type
13.7.1. For Peripartum Cardiomyopathy
13.7.2. For Inherited Arrythmias
13.7.3. For Congenital Heart Disease
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Wearable Cardioverter Defibrillators Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Wearable Cardioverter Defibrillators Market: Market Share Analysis
14.2. Wearable Cardioverter Defibrillators Distributors and Customers
14.3. Wearable Cardioverter Defibrillators Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Boston Scientific
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. St. Jude Medical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Medtronic
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Nihon Kohden
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Zoll Medical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
